IRIS
MARRELLI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.403
EU - Europa 24.790
AS - Asia 13.087
SA - Sud America 2.171
AF - Africa 761
Continente sconosciuto - Info sul continente non disponibili 697
OC - Oceania 48
Totale 72.957
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.941
GB - Regno Unito 5.244
RU - Federazione Russa 4.719
CN - Cina 4.534
IT - Italia 4.261
SG - Singapore 4.010
IE - Irlanda 3.044
BR - Brasile 1.802
UA - Ucraina 1.763
SE - Svezia 1.518
FR - Francia 1.430
VN - Vietnam 1.323
DE - Germania 1.257
HK - Hong Kong 1.078
FI - Finlandia 666
KR - Corea 581
IN - India 340
ZA - Sudafrica 314
BD - Bangladesh 285
CA - Canada 222
ES - Italia 189
AR - Argentina 139
MX - Messico 124
NL - Olanda 122
IQ - Iraq 120
NG - Nigeria 119
TR - Turchia 118
PL - Polonia 97
BE - Belgio 93
JP - Giappone 93
ID - Indonesia 79
CI - Costa d'Avorio 75
PK - Pakistan 59
IR - Iran 53
SA - Arabia Saudita 53
AT - Austria 52
EG - Egitto 50
EC - Ecuador 44
RO - Romania 44
JO - Giordania 43
LT - Lituania 43
KE - Kenya 41
VE - Venezuela 41
MA - Marocco 39
AU - Australia 38
UZ - Uzbekistan 35
PH - Filippine 33
PT - Portogallo 33
PY - Paraguay 33
CL - Cile 32
CZ - Repubblica Ceca 30
CO - Colombia 29
NP - Nepal 29
AE - Emirati Arabi Uniti 28
MU - Mauritius 27
TN - Tunisia 26
AZ - Azerbaigian 25
CH - Svizzera 25
MY - Malesia 24
KG - Kirghizistan 23
PE - Perù 21
JM - Giamaica 20
DZ - Algeria 19
UY - Uruguay 19
IL - Israele 18
KZ - Kazakistan 18
GR - Grecia 17
CR - Costa Rica 16
ET - Etiopia 16
EU - Europa 16
AL - Albania 14
SI - Slovenia 14
BG - Bulgaria 13
LV - Lettonia 12
TH - Thailandia 12
PA - Panama 11
SN - Senegal 11
TW - Taiwan 11
EE - Estonia 10
HN - Honduras 10
MD - Moldavia 10
NI - Nicaragua 10
BO - Bolivia 9
DK - Danimarca 9
NZ - Nuova Zelanda 9
RS - Serbia 9
TT - Trinidad e Tobago 9
GT - Guatemala 8
HU - Ungheria 8
DO - Repubblica Dominicana 7
HR - Croazia 7
NO - Norvegia 7
SV - El Salvador 7
AO - Angola 6
BH - Bahrain 6
BY - Bielorussia 6
SY - Repubblica araba siriana 6
AM - Armenia 5
CY - Cipro 5
GE - Georgia 5
Totale 72.178
Salva come PNG Salva come JPEG
Città #
Southend 4.666
Dallas 4.045
Fairfield 3.121
Dublin 3.012
Ashburn 2.378
Singapore 2.118
Chandler 1.561
Jacksonville 1.526
Santa Clara 1.411
Woodbridge 1.371
Moscow 1.321
San Jose 1.245
Wilmington 1.178
Milan 1.154
Seattle 1.144
Houston 1.110
Beijing 1.041
Hong Kong 1.035
Cambridge 991
Council Bluffs 903
Ann Arbor 780
Hefei 642
Princeton 576
Seoul 562
Nanjing 479
The Dalles 455
Los Angeles 426
New York 401
Ho Chi Minh City 396
Rome 388
Siena 386
Munich 340
Lauterbourg 336
Hanoi 322
Johannesburg 278
Helsinki 270
Columbus 250
Boardman 228
San Mateo 227
Shanghai 190
São Paulo 184
Florence 182
San Diego 171
Buffalo 169
Shenyang 146
Nanchang 141
Orem 123
Málaga 117
Abuja 110
London 108
Figino 104
Redondo Beach 101
Tianjin 98
Frankfurt am Main 92
Dong Ket 89
Hebei 89
Brussels 85
Changsha 81
Düsseldorf 78
San Francisco 78
Turku 78
Abidjan 75
Tokyo 74
Warsaw 72
Turin 71
Chicago 69
Kunming 68
Jiaxing 66
Montreal 66
Phoenix 66
Da Nang 65
Jinan 62
Toronto 59
Bengaluru 57
Brooklyn 57
Naples 57
Atlanta 56
Guangzhou 56
Manchester 56
Rio de Janeiro 56
Chennai 55
Boston 53
Denver 53
Dearborn 50
Menlo Park 48
Ningbo 46
Norwalk 46
Stockholm 46
Venezia 46
Zhengzhou 45
Bologna 44
Mexico City 44
Haiphong 42
Washington 42
Belo Horizonte 41
Baghdad 40
Lappeenranta 40
Amman 38
Mumbai 38
Brasília 37
Totale 48.789
Salva come PNG Salva come JPEG
Nome #
Patologie del duodeno 688
612. Molecular background of high risk and low risk areas of gastric cancer in Italy 484
Clinical Outcome of Primary and Postoperative Visceral Perforations 394
354. KRAS mutation in gastric cancer- molecular, and clinico-pathological characteristic 380
Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) 378
Gastric cancer maximum tumour diameter reduction rate at CT examination as a radiological index for predicting histopathological regression after neoadjuvant treatment: A multicentre GIRCG study 364
530. Minimally invasive surgery for the treatment of colo-rectal adenocarcinoma: Laparoscopic and robotic approach 359
65. Molecular surgery for gastric cancer-role of microsatellite instability in elderly patients 355
613. Lymph node metastases in microsatellite unstable gastric cancer 346
338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer 343
C-Met targeting in advanced gastric cancer: An open challenge 342
A case of pancreatic somatostatinoma [Considerazioni su un caso di somatostatinoma a localizzazione pancreatica] 331
A clinical case of duodenal gastrointestinal stromal tumor with a peculiarity in the surgical approach. 328
Clinical evaluation of the Mannheim Prognostic Index in post-operative peritonitis: a prospective cohort study 328
611. Gastric cancer patients with familial aggregation of gastric cancer and Lynch syndrome associated cancers with microsatellite instability 327
353. PIK3CA mutation in gastric cancer and the role of different codon mutations in the new molecular division of that neoplasm 326
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 321
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 319
Accuracy of MDCT in the Preoperative Definition of Peritoneal Cancer Index (PCI) in Patients with Advanced Ovarian Cancer Who Underwent Peritonectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 316
610. Heterogeneity of new molecular gastric cancer classifications. Clinico-pathological characteristic 312
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 310
Age Related Co-Morbidities in Colorectal Cancer Patients: Surgical Problems and Prognostic Impact 304
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 299
A case of small-cell gastric carcinoma with an adenocarcinoma component and hepatic metastases: treatment with systemic and intra-hepatic chemotherapy 298
Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence 298
Familial aggregation of gastric cancer with microsatellite instability** 290
Complications after surgery for gastric cancer in patients aged 80 years and over 288
Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases 284
Comparison between 7th and 8th edition of AJCC TNM staging system for gastric cancer: Old problems and new perspectives 284
Western Experience of Hepatolithiasis: Clinical Insights from a Case Series in a Tertiary Center 283
Recurrence after surgery in esophago-gastric junction adenocarcinoma: Current management and future perspectives 283
Robotic versus laparoscopic gastrectomy for gastric cancer: protocol for umbrella review of systematic reviews and meta-analyses 283
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer 283
High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability 281
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 280
A new way to experience the International Gastric Cancer Association Congress: the Web Round Tables 279
A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. 279
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status 278
Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability 278
CA 19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions 278
Clinical impact of molecular classifications in gastric cancer 274
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. 272
A rare case of primary small bowel adenocarcinoma with intussusception. 272
Re-evaluation of Mannheim prognostic index in perforative peritonitis: Prognostic role of advanced age. A prospective cohort study 271
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 270
The pattern of lymph node metastases in microsatellite unstable gastric cancer 268
Hyperthermic intrathoracic chemotherapy after extended pleurectomy and decortication for malignant pleura mesothelioma: An observational study on outcome and microcirculatory changes 268
Signet ring cell percentage in poorly cohesive gastric cancer patients: a potential novel predictor of survival 268
Antimicrobial prophylaxis reduces the rate of surgical site infection in upper gastrointestinal surgery: a systematic review 268
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 267
A comprehensive PDX gastric cancer collection captures cancer cell–intrinsic transcriptional MSI traits 267
Accuracy of MDCT in preoperative definition of maximum tumour diameter in patients with gastric cancer 266
Computed Tomographic Evaluation of Mesentery : Diagnostic Value in Acute Mesenteric Ischemia. 265
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 265
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 264
K-RAS mutation in gastric cancer and its link with microsatellite instability status 264
E-cadherin and hereditary diffuse gastric cancer. 262
Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer 261
CDH1 C-160A promoter polymorphism and gastric cancer risk 260
Is sleeve gastrectomy a therapeutic procedure for all obese patients? 259
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 257
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 257
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer 256
Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases 255
Accuracy of MDCT in preoperative definition of maximum tumor diameter in patients with gastric cancer 255
The percentage of signet ring cells is inversely related to aggressive behavior and poor prognosis in mixed-type gastric cancer 254
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an italian family 253
Clinical and oncological value of preoperative BMI in gastric cancer patients: A single center experience 251
Evidence of tumor microsatellite instability in gastric cancer with familial aggregation 251
Presacral ganglioneuroma: a case report and review of literature 250
Accuracy of MDCT in preoperative definition of maximum tumor diameter in patients with gastric cancer 249
Robotic single docking total colectomy for ulcerative colitis: First experience with a novel technique 247
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer 247
Carcinomi squamosi e adenosquamosi del colon-retto: descrizione di tre casi clinici e revisione della letteratura 245
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 245
Potential impact of molecular classification on tailored lymphadenectomy for gastric cancer 239
Gastrointestinal stromal tumors (GIST): a proposal of a “CT-based predictive model of Miettinen index” in predicting the risk of malignancy 239
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 238
Treatment of the intraabdominal abscesses through percutaneous ultrasound-guided drainage in oncological patients: Clinical and microbiological data. 238
Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy. 236
Factors influencing survival after hepatectomy for metastases from gastric cancer 235
High incidence of familial gastric cancer in Tuscany, a region in Italy. 235
Elastofibroma dorsi: three cases of personal experience 235
Clinical Utility of Serum Tumor Markers Assay in Patients Admitted for Intestinal Occlusion 234
Approccio multimodale al trattamento delle metastasi epatiche. 234
Il ruolo della chemioipertermia nel carcinoma del colon-retto 234
Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. 234
Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study 233
Super-extended (D3) lymphadenectomy in advanced gastric cancer. 232
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 231
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 231
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study 230
Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial 228
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 228
Gastric linitis plastica: which role for surgical resection? 227
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data 227
Cell kinetic patterns in early gastric cancer 226
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene 226
Handgrip strength predicts length of hospital stay in an abdominal surgical setting: the role of frailty beyond age 225
609. Pathology of signet-ring cell in gastric cancer and its prognostic value in surgical treatment 225
Totale 27.984
Salva come PNG Salva come JPEG
Categoria #
all - tutte 221.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 221.614
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.913 0 532 279 293 218 167 208 147 224 463 477 905
2022/20235.840 341 373 789 836 563 1.286 142 447 583 167 165 148
2023/20244.459 217 137 364 158 149 1.175 1.637 82 25 154 58 303
2024/20259.549 312 500 780 474 1.268 666 233 563 817 385 1.098 2.453
2025/202624.930 1.782 3.598 2.863 2.648 4.341 968 2.685 718 950 1.318 962 2.097
2026/20272.030 1.193 837 0 0 0 0 0 0 0 0 0 0
Totale 72.957